Class III ยท Low risk
Revcovi (elapegademase-lvlr)
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
National Drug Code
Is NDC 10122-0502-01 recalled?
Revcovi · 1 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIAL
Yes — this exact package was recalled
1 FDA recall names the code 10122-0502-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
1 of these recalls is still ongoing.
- Active ingredient
- elapegademase-lvlr
- Strength
- ELAPEGADEMASE 1.6 mg/mL
- Form
- Injection · Intramuscular
- Labeler
- Chiesi USA, Inc.
- Type
- Human Prescription Drug
- Product code
- 10122-0502
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 10122-0510 Curosurf 1
- 10122-0611 Cleviprex 1
- 10122-0820 Bethkis 1
- 10122-0902 See recall 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.